We advised Kindstar Global on its IPO and HKEX listing

Davis Polk advised Kindstar Globalgene Technology, Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A and Regulation S. The gross proceeds from the offering amounted to HK$2.21 billion (US$283.8 million) prior to exercise of the over-allotment option.

Kindstar Global is a leading independent esoteric clinical testing service provider in China. It has the largest esoteric testing portfolio among all the independent esoteric testing providers in China, with over 3,500 testing items in their service menu, which includes over 2,300 testing items for hematology.

The Davis Polk corporate team included partners Yang Chu, Li He and Xuelin (Steve) Wang, counsel Lillian Lian and registered foreign lawyers Lulu Han and Iris Li. Alon Gurfinkel and associate Veronica Davis provided tax advice. Members of the Davis Polk team are based in the Hong Kong, Beijing and London offices.

Copy link to share post